- Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
Shinya Matsuzaki et al, 2015, Cancer Cell International CrossRef - Novel Anti-angiogenic Therapies Using Naturally Occurring and Synthetic Drugs to Combat Progestin-Dependent Breast Cancer
Salman M. Hyder et al, 2013, Cell and Molecular Biology of Breast Cancer CrossRef - Essential role of autophagy in fucoxanthin-induced cytotoxicity to human epithelial cervical cancer HeLa cells
Li-li Hou et al, 2013, Acta Pharmacologica Sinica CrossRef - Targeting DNA repair and replication stress in the treatment of ovarian cancer
Junko Murai, 2017, International Journal of Clinical Oncology CrossRef - Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival
Feng Zhou et al, 2014, Clinical Chemistry and Laboratory Medicine CrossRef - SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway
X Peng et al, 2014, Cell Death & Disease CrossRef - Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53
SEE-HYOUN G PARK et al, 2014, International Journal of Oncology CrossRef - Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer
Jianling Bi et al, 2022, Cell Death & Disease CrossRef - A review on hepatocyte nuclear factor-1beta and tumor
Dan-Dan Yu et al, 2015, Cell & Bioscience CrossRef - A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer
Harsh B. Pathak et al, 2015, PLOS ONE CrossRef - Hepatocyte nuclear factor 1 beta: A perspective in cancer
Shubhra Chandra et al, 2021, Cancer Medicine CrossRef - An association of iNKT+/CD3+/CD161+ lymphocytes in ovarian cancer tissue with CA125 serum concentration
Izabela Winkler et al, 2020, Immunobiology CrossRef - Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2/Akt/FOXO3 pathway in ovarian cancer cells
Jun Sang Bae et al, 2017, Oncology Reports CrossRef